Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases
- PMID: 8774170
- PMCID: PMC1010215
- DOI: 10.1136/ard.55.7.486
Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases
Abstract
Objective: To study maternal and fetal outcome of pregnancy in patients with lupus who were exposed to hydroxychloroquine (HCQ).
Methods: The case records of women (n = 33) exposed to HCQ during their pregnancies (n = 36) and of 53 control patients from a single lupus pregnancy centre were reviewed to determine lupus activity, obstetric experience, and infant outcome.
Results: HCQ was not apparently teratogenic. Lupus activity and obstetric outcome in the two groups were similar.
Conclusion: HCQ continuation is probably safe during pregnancy in patients with lupus, but there is no obvious advantage in commencing treatment.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
